Nonprofit · EIN 58-1654301
RHEUMATOLOGY RESEARCH FOUNDATION
Tax-exempt · ATLANTA, GA 30326
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $19,785,814 | $17,070,676 | $2,715,138 | $76,434,619 | $3,409,238 | $73,025,381 |
| June 30, 2024 | 990 | $13,965,881 | $17,398,192 | -$3,432,311 | $70,729,610 | $1,605,570 | $69,124,040 |
| June 30, 2023 | 990 | $13,039,465 | $17,402,769 | -$4,363,304 | $70,496,543 | $501,818 | $69,994,725 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $14,078,487
- Program service revenue
- $0
- Investment income
- $5,707,327
- Net gain from sales of assets
- $4,502,163
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $11,735,721
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Legal fees
- $53,063
- Accounting fees
- $55,894
- Travel
- $506,980
- Program services (functional)
- $14,441,757
- Management and general (functional)
- $645,443
- Fundraising (functional)
- $1,983,476
Balance sheet and other
- Total assets, start of year
- $70,729,610
- Total assets, end of year
- $76,434,619
- Total liabilities, end of year
- $3,409,238
- Net assets, end of year
- $73,025,381
- Publicly traded securities
- $58,299,770
- Net assets without donor restrictions
- $42,827,537
- Net assets with donor restrictions
- $30,197,844
- Gross receipts
- $65,779,017
- Employees
- 0
- Volunteers
- 0
- Year formed
- 1985
- State of legal domicile
- IL
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Colleen Merkel | VP, Operations and Finance Key employee | 1 | $0 | $246,081 | $49,300 |
| Rachel Myslinski | Executive Director Key employee | 1 | $0 | $228,633 | $45,590 |
| Paula Reed | VP, Philanthropy Key employee | 1 | $0 | $177,196 | $31,255 |
| Eryn Marchiolo | VP, Mission Key employee | 1 | $0 | $170,399 | $30,479 |
| Mona Bhavsar | Sr. Director, Controller Key employee | 1 | $0 | $150,824 | $36,237 |
| Kay Butts-Pruett | Sr. Director, Philanthropy Highest-paid employee | 1 | $0 | $135,699 | $26,649 |
| Lauren Adalfio | Senior Manager, Finance Highest-paid employee | 1 | $0 | $124,549 | $33,836 |
| Benjamin Walkuski | Director, Individual Engagement & Philanthropy Highest-paid employee | 1 | $0 | $120,925 | $25,615 |
| Colette Novak | Director, Data Strategy Highest-paid employee | 1 | $0 | $101,580 | $31,830 |
| Michael Greer | Director, Philanthropy Officer Highest-paid employee | 1 | $0 | $103,524 | $28,219 |
| Liana Fraenkel MD MPH | Foundation President (2023-2025) Trustee or director, Officer | 14 | $0 | $69,000 | $0 |
| Anne Bass MD | Treasurer (2023-2025) Trustee or director, Officer | 14 | $0 | $47,300 | $0 |
| Bryce Binstadt MD PhD | Foundation Vice President (2023-2025) Trustee or director, Officer | 14 | $0 | $3,434 | $0 |
| Edward Behrens MD | Chair, Scientific Advisory Council (2023-2026) Trustee or director | 2 | $0 | $2,956 | $0 |
| Alexis Ogdie MD | Member at Large (2024-2027) Trustee or director | 2 | $0 | $2,500 | $0 |
15 more people on this return
| Name | Title | Hours / week | Compensation | From related orgs |
|---|---|---|---|---|
| Susan Bartlett PhD | ARP Representative (2024-2027) Trustee or director | 2 | $0 | $2,385 |
| Alfred Kim MD PhD | Chair, Impact Advisory Council (2023-2026) Trustee or director | 2 | $0 | $1,000 |
| Angus Worthing MD | Secretary (2024-2026) Trustee or director | 2 | $0 | $0 |
| Anisha Dua MD | Chair, ACR Committee on Training (2024-2027) Trustee or director | 2 | $0 | $0 |
| Carol Young MD | Member at Large (2022-2025) Trustee or director | 2 | $0 | $0 |
| Charles Saia | Member at Large (2024-2027) Trustee or director | 2 | $0 | $0 |
| Corinne Karp MAEd | Member at Large (2022-2025) Trustee or director | 2 | $0 | $0 |
| Firas Kassab MD | Member at Large (2022-2025) Trustee or director | 2 | $0 | $0 |
| Jay Norman | Member at Large (2024-2027) Trustee or director | 2 | $0 | $0 |
| Jody Hargrove MD | Chair, Development Advisory Council (2022-2025) Trustee or director | 2 | $0 | $0 |
| Linda Hiraki MD MS ScD | ACR Research Representative (2023-2026) Trustee or director | 2 | $0 | $0 |
| M Elaine Husni MD | Member at Large (2023-2026) Trustee or director | 2 | $0 | $0 |
| Rina Joshi DO | Fellow-In-Training Representative (2024-2025) Trustee or director | 2 | $0 | $0 |
| Ryan DeMassi MD | Corporate Roundtable Representative - 2023-2025 Trustee or director | 2 | $0 | $0 |
| Ted Mikuls MD MSHP | Member at Large (2023-2026) Trustee or director | 2 | $0 | $0 |
990 for the year ended June 30, 2024: 32 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Colleen Merkel CPA | VP, Operations and Finance Key employee | 1 | $0 | $242,013 | $50,858 |
| Rachel Myslinski | Executive Director Key employee | 1 | $0 | $215,764 | $46,022 |
| Paula Reed | VP, Philanthropy Key employee | 1 | $0 | $175,217 | $29,869 |
| Eryn Marchiolo | VP, Mission Highest-paid employee | 1 | $0 | $170,084 | $29,110 |
| Katherine Butts-Pruett | Sr. Director, Philanthropy Highest-paid employee | 1 | $0 | $132,113 | $26,121 |
| Shelley Malcolm | Sr. Director, Impact Highest-paid employee | 1 | $0 | $121,222 | $24,447 |
| Benjamin Walkuski | Director, Individual Engagement & Philanthropy Highest-paid employee | 1 | $0 | $119,377 | $24,201 |
| V Michael Holers MD | Foundation President (2021 - 2023) Trustee or director, Officer | 14 | $0 | $69,000 | $0 |
| Carol Langford MD MHS | Treasurer (2021 - 2023) Trustee or director, Officer | 14 | $0 | $49,300 | $0 |
| William Harvey MD | Secretary Trustee or director, Officer | 2 | $0 | $26,150 | $0 |
| Bethany Marston MD | ACR Training Rep Trustee or director | 2 | $0 | $6,250 | $0 |
| Ann Bass MD | Treasurer Trustee or director, Officer | 14 | $0 | $6,000 | $0 |
| Kristine A Kuhn MD PhD | ACR Research Rep (2020-2023) Trustee or director | 2 | $0 | $5,000 | $0 |
| Bryce Binstadt MD PhD | Foundation Vice President Trustee or director, Officer | 14 | $0 | $4,459 | $0 |
| Edward Behrens MD | Chair, Scientific Advisory Trustee or director | 2 | $0 | $4,199 | $0 |
| Liana Fraenkel MD | Foundation President Trustee or director, Officer | 14 | $0 | $2,750 | $0 |
| Ted Mikuls MD | Member at Large Trustee or director | 2 | $0 | $1,500 | $0 |
| Alfred Kim MD PhD | Chair, Impact Adv Council Trustee or director | 2 | $0 | $0 | $0 |
| Bernie Rubin DO MPH | Corporate Rountable Rep (2021-2023) Trustee or director | 2 | $0 | $0 | $0 |
| Carol Young MD | MEmber at Large Trustee or director | 2 | $0 | $0 | $0 |
| Carrie Hansen | Member at Large Trustee or director | 2 | $0 | $0 | $0 |
| Corinne Karp MAEd | MEmber at Large Trustee or director | 2 | $0 | $0 | $0 |
| Elain Husni MD | Member at Large Trustee or director | 2 | $0 | $0 | $0 |
| Firas Kassab MD | MEmber at Large Trustee or director | 2 | $0 | $0 | $0 |
| Jody Hargrove MD | Chair, Development Advisor Trustee or director | 2 | $0 | $0 | $0 |
| Leo Wegemer JD LLM | Member at Large Trustee or director | 2 | $0 | $0 | $0 |
| Linda Hiraki MD MS ScD | ACR Research Rep Trustee or director | 2 | $0 | $0 | $0 |
| Marian Hannan DSc MPH | ARP Rep Trustee or director | 2 | $0 | $0 | $0 |
| Marta Bean MD | Fellow-in-Training Trustee or director | 2 | $0 | $0 | $0 |
| Ryan DeMasi MD | Corporate Rountable Rep Trustee or director | 2 | $0 | $0 | $0 |
| Steve Russell MBA | Chair, Impact Adv Council (2020-2023) Trustee or director | 2 | $0 | $0 | $0 |
| Vikas Majithia MD MPH FACR FACP | Member at Large Trustee or director | 2 | $0 | $0 | $0 |
990 for the year ended June 30, 2023: 26 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| COLLEEN MERKEL CPA | VP, OPERATIONS AND FINANCE Key employee | 1 | $0 | $240,516 | $43,513 |
| RACHEL MYSLINSKI | EXECUTIVE DIRECTOR Key employee | 1 | $0 | $200,302 | $50,404 |
| ERYN MARCHIOLO | VP, MISSION Key employee | 1 | $0 | $160,178 | $26,775 |
| KATHERINE BUTTS-PUETT | SR. DIRECTOR, PHIL Highest-paid employee | 1 | $0 | $127,676 | $24,152 |
| BENJAMIN WALKUSKI | DIRECTOR, IND ENG AND PHIL Highest-paid employee | 1 | $0 | $117,242 | $22,205 |
| PAULA ISLEY | REG PHIL OFFICER, WEST Highest-paid employee | 1 | $0 | $115,270 | $23,519 |
| RHONDA ARMSTRONG | SR. DIRECTOR, FINANCE Highest-paid employee | 1 | $0 | $114,623 | $20,130 |
| SHELLEY MALCOLM | SR. DIRECTOR, IMPACT Highest-paid employee | 1 | $0 | $112,286 | $22,087 |
| V MICHAEL HOLERS MD | FOUNDATION PRESIDENT Trustee or director, Officer | 14 | $0 | $69,000 | $0 |
| LIANA FRAENKEL MD | FOUNDATION VICE PRESIDENT Trustee or director, Officer | 14 | $47,300 | $0 | $0 |
| MARIAN HANNAN DSC MPH | ARP REP Trustee or director | 2 | $0 | $5,500 | $0 |
| BETHANY MARSTON MD | ACR TRAINING REP Trustee or director | 2 | $0 | $5,250 | $0 |
| KRISTINE A KUHN MD PHD | ACR RESEARCH REP Trustee or director | 2 | $0 | $5,000 | $0 |
| BRYCE BINSTADT MD PHD | MEMBER AT LARGE Trustee or director | 2 | $0 | $2,941 | $0 |
| CAROL LANGFORD MD MHS | TREASURER Trustee or director, Officer | 14 | $0 | $0 | $0 |
| JODY HARGROVE MD | CHAIR, DEVELOPMENT ADVISOR Trustee or director | 2 | $0 | $0 | $0 |
| TED MIKULS MD | CHAIR, SCIENTIFIC ADVISORY Trustee or director | 2 | $0 | $0 | $0 |
| STEVE RUSSELL MBA | CHAIR, IMPACT ADV COUNCIL Trustee or director | 2 | $0 | $0 | $0 |
| BERNIE RUBIN DO MPH | CORPORATE ROUNTABLE REP Trustee or director | 2 | $0 | $0 | $0 |
| ELAIN HUSNI MD | MEMBER AT LARGE Trustee or director | 2 | $0 | $0 | $0 |
| LEO WEGEMER JD LLM | MEMBER AT LARGE Trustee or director | 2 | $0 | $0 | $0 |
| VIKAS MAJITHIA MD MPH FACR FACP | MEMBER AT LARGE Trustee or director | 2 | $0 | $0 | $0 |
| CARRIE HANSEN | MEMBER AT LARGE Trustee or director | 2 | $0 | $0 | $0 |
| CAROL YOUNG MD | MEMBER AT LARGE Trustee or director | 2 | $0 | $0 | $0 |
| CORINNE KARP | MEMBER AT LARGE Trustee or director | 2 | $0 | $0 | $0 |
| FIRAS KASSAB MD | MEMBER AT LARGE Trustee or director | 2 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 3379 PEACHTREE RD NE STE 700, ATLANTA, GA 30326-1419
- Principal officer (990 for 2024)
- Eryn Marchiolo, 2200 Lake Boulevard NE, Atlanta, GA 30319
- Signed the 990
- Eryn Marchiolo, Executive Director
- Phone
- (404) 633-3777
- Website
- www.rheumresearch.org
- Return prepared by
- Forvis Mazars LLP
Mission
THE MISSION OF THE RHEUMATOLOGY RESEARCH FOUNDATION IS TO ADVANCE RESEARCH AND TRAINING TO IMPROVE THE HEALTH OF PEOPLE WITH RHEUMATIC DISEASES.
Program accomplishments
- FOUNDATION PROGRAMS SUPPORT RESEARCH INVESTIGATING THE BROAD SPECTRUM OF RHEUMATIC DISEASES, INCLUDING but not limited to: JUVENILE IDIOPATHIC ARTHRITIS, OSTEOARTHRITIS, PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS, SCLERODERMA, SPONDYLOARTHROPATHIES, SYSTEMIC LUPUS ERYTHEMATOSUS, AND VASCULITIS. PLEASE SEE SCHEDULE O FOR A CONTINUATION OF PROGRAM SERVICES. The Rheumatology Research Foundation maintains an extensive awards and grants portfolio, with 22 support mechanisms for rheumatologists and rheumatology health professionals in the U.S. Each grant application contains very specific eligibility and review criteria (details regarding these requirements are available at www.rheumresearch.org). All applications undergo rigorous peer review in their assigned study section, and are scored and ranked according to the review criteria and overall merit of the proposal. All study section recommendations are sent to the Foundation's Scientific Advisory Council for qualification before being presented (blinded) to the Foundation Board of Directors for final approval. After the awards are made, all recipients are required to complete funding contracts with institutional sign-off, and must also submit annual reports on their progress, including financial reconciliation and assurance of compliance with Foundation policies (available on the website). All reports are reviewed by the Foundation's Scientific Advisory Council to ensure compliance with programmatic, scientific, fiscal, and administrative polices and requirements. If a recipient is found to be in compliance and making reasonable progress (i.e. meeting project benchmarks), the next year of funding is approved for disbursement. If not, the award may be terminated. Such programmatic oversight allows for excellent stewardship of Foundation funds. In additional to regular oversight as described above, portfolio review are conducted every five years to ensure that funding mechanisms are effectively meeting the Foundation's goals outlined in the strategic plan. In addition, the Rheumatology Research Foundation abides by the following conflict of interest guidelines: Guidelines for awarding of Foundation awards and grants I. The Foundation will not permit and external entities to select (or influence the selection of) recipients of Foundation awards or grants. II. The Foundation will appoint independent committees to select recipients of Foundation awards or grants based on peer review of grant applications. III. The Foundation will not require recipients of Foundation awards or grants to meet with external entities. IV. The Foundation will not permit any external entity that supports Foundation awards or grants to require intellectual property rights or royalties arising out of the grant-funded research. V. The Foundation will not permit any external entity that supports Foundation awards or grants to control or influence manuscripts that arise from the grant-funded research. The Foundation provides funding to help recruit students and residents into the subspecialty and supports investigators and practitioners working in the field of rheumatology. Grants are awarded for different training opportunities, from undergraduate students to established investigators, building a more capable, robust team of rheumatology professionals around the nation. In the last five years, researchers receiving Foundation funding have published 451 papers, received $133.5M in related NIH funding, and given 69 scientific presentations at the ACR Convergence meeting. The Foundation is a 501(c)(3) charitable organization dedicated to advancing treatment for people living with rheumatic disease and is the largest private funding source of rheumatology research and training in the United States. The organization has received a 4-star rating, the highest offered by Charity Navigator, for sixteen consecutive years based on good governance, sound fiscal management, and commitment to accountability and transparency. The organization has committed over $243M directly to research and training since it was founded in 1985 by the granting of 4,982 individual awards.Expenses $14,441,757 · grants $11,735,721
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 58-1654301
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1988
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H110)
- Assets (IRS master file)
- $76,434,619
- Income (IRS master file)
- $65,779,017
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $19,785,814 | $17,070,676 | $76,434,619 | XML |
| 990 | June 2024 | $13,965,881 | $17,398,192 | $70,729,610 | XML |
| 990 | June 2023 | $13,039,465 | $17,402,769 | $70,496,543 | XML |
| 990 | June 2022 | $7,906,919 | $16,411,503 | $70,647,398 | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990 | June 2020 | – | – | – | IRS |
| 990 | June 2019 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 58-1654301).
Questions about RHEUMATOLOGY RESEARCH FOUNDATION
- What is the EIN of RHEUMATOLOGY RESEARCH FOUNDATION?
- The employer identification number (EIN) of RHEUMATOLOGY RESEARCH FOUNDATION is 58-1654301.
- Is RHEUMATOLOGY RESEARCH FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1988.
- Are donations to RHEUMATOLOGY RESEARCH FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does RHEUMATOLOGY RESEARCH FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of RHEUMATOLOGY RESEARCH FOUNDATION due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did RHEUMATOLOGY RESEARCH FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of RHEUMATOLOGY RESEARCH FOUNDATION?
- The 990 for the year ended June 30, 2025 names Eryn Marchiolo.
- Who are the officers and directors of RHEUMATOLOGY RESEARCH FOUNDATION?
- The 990 for the year ended June 30, 2025 lists 30 people; 0 received compensation from the organization.
- How much revenue does RHEUMATOLOGY RESEARCH FOUNDATION have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $19,785,814, expenses of $17,070,676 and total assets of $76,434,619 at year end.
Other nonprofits in ATLANTA
- CURE CHILDHOOD CANCER INC EIN 58-1244138 · last filed 990 for 2025
- GEORGIA CENTER FOR ONCOLOGY RESEARCH AND EDUCATION INC EIN 57-1159979 · last filed 990 for 2025
- SOUTHERN LIGHT RAIL INC EIN 30-0240711 · last filed 990 for 2025
- EMPOWERMENT RESOURCE CENTER INC EIN 56-2587827 · last filed 990 for 2024
- EMTECH INC EIN 58-2585997 · last filed 990 for 2025
- ADEWUNMI DESALU PARKINSONS FOUNDATION INC EIN 92-2377265 · last filed 990 for 2025
- ODYLIA THERAPEUTICS INC EIN 82-2120760 · last filed 990 for 2025
- METABOLOMICS SOCIETY INC EIN 32-0107582 · last filed 990 for 2025